Cargando…
CD70 CAR T cells in AML: Form follows function
Using a multimodal approach toward developing a new CD70-targeted Chimeric antigen receptor (CAR) T cell in acute myeloid leukemia, Leick et al.(1) report on their synergetic strategy, which incorporates both CAR T cell construct modifications with enhancement of leukemia antigen expression to impro...
Autores principales: | Mirazee, Justin, Shah, Nirali N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133448/ https://www.ncbi.nlm.nih.gov/pubmed/35584621 http://dx.doi.org/10.1016/j.xcrm.2022.100639 |
Ejemplares similares
-
A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms
por: Talleur, Aimee C., et al.
Publicado: (2023) -
CD8(+) T cells: An ineffective armor against prolonged COVID-19 in cancer patients
por: Van Oekelen, Oliver, et al.
Publicado: (2022) -
Function through absence: Active RNA exclusion from chromosomes leads to proper cell division
por: Teves, Sheila S.
Publicado: (2020) -
Sex-biased Immune Responses Following SARS-CoV-2 Infection
por: Ursin, Rebecca L., et al.
Publicado: (2020) -
Emerging CAR T Cell Strategies for the Treatment of AML
por: Vishwasrao, Paresh, et al.
Publicado: (2022)